Biotechnology and bioinformatics applications in alzheimer’s disease

3Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Alzheimer’s disease is one of the most severe types of dementia that causes problems with memory, thinking, and behavior. Biotechnology and bioinformatics are nowadays involved in the establishment of advanced methods of diagnosis and treatment, including molecular medicine, personalized medicine, gene identification and manipulation, as well as neural engineering. Next-generation sequencing is one of the strongest tools for studying genetic diseases and gene mutations. Additionally, brain-computer interface could be used in the near future to assist people with paralysis or other related disorders and physical injuries to move toward into a better way of life, restoring memory or improving the way of everyday life. This chapter aims to provide an overview of the most common and an advanced application of biotechnology and bioinformatics in Alzheimer’s including the genome-wide association studies and the role of microbiome detection in Alzheimer’s disease.

Cite

CITATION STYLE

APA

Ali, M. A., Alexiou, A., & Ashraf, G. M. (2019). Biotechnology and bioinformatics applications in alzheimer’s disease. In Biological, Diagnostic and Therapeutic Advances in Alzheimer’s Disease: Non-Pharmacological Therapies for Alzheimer’s Disease (pp. 223–234). Springer Singapore. https://doi.org/10.1007/978-981-13-9636-6_12

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free